{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-089566","form_type":"8-K","ticker":"ADVB","cik":"0001941029","company_name":"Advanced Biomed Inc.","filed_at":"2025-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.659789+00:00","generated_at":"2026-05-17T06:09:15.915004+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Advanced Biomed launches A+PerfusC 3D cell culture platform for precision medicine","bullets":["A+PerfusC is a compact perfusion 3D cell culture incubator with automated perfusion and environmental control, mountable on a microscope for real-time observation.","System supports up to 12 days continuous culture, 8 independent channels per plate, 600 tumor spheroids per row, and 4,800 spheroids per plate.","Global 3D cell culture market valued at $2.32B in 2025, projected to exceed $4.71B by 2030 (CAGR >15.6%) per Mordor Intelligence.","Mass-production development is ongoing; commercialization will follow finalization of mass production and quality control standards.","Potential applications include personalized oncology, drug screening, regenerative medicine, organoid studies, and stem cell research."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-089566","json":"https://secwatch.observer/filing/0001213900-25-089566.json","markdown":"https://secwatch.observer/filing/0001213900-25-089566.md","text":"https://secwatch.observer/filing/0001213900-25-089566.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1941029/000121390025089566/0001213900-25-089566-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1941029/000121390025089566/ea0258116-8k_advanced.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:09:15.915004+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}